Shorts

0:42
T-Cell Therapies Push Blood Cancer Treatment Forward
2 months ago
by
Krish Patel, MD

1:37
How Etentamig Stands Out From Other BCMA Bispecifics
2 months ago
by
Peter Voorhees, MD

0:51
Why Do Promising Cancer Drugs Fail in Phase 3?
2 months ago
by
David DiBardino, MD

0:31
Your Wednesday Oncology Wrap-Up - September 16
2 months ago
by
Sabrina Serani

0:45
Unlocking HER2 Beyond Breast Cancer
2 months ago
by
Aditya Shreenivas, MD, MS

0:39
MSOs: A Support System for Physicians
2 months ago
by
Marcus Neubauer, MD

0:46
How AI Could Take the Guesswork Out of Payer Policies
2 months ago
by
Marcus Neubauer, MD

0:31
Why No Oncologist Is Immune to Burnout
2 months ago
by
Marcus Neubauer, MD

0:31
The Truth About Clinical Trial Enrollment
2 months ago
by
Noelle Gillette Cloven, MD

0:34
Tackling the Health Care Interoperability Problem
2 months ago
by
Marcus Neubauer, MD

0:31
The "Holy Grail" of Lung Cancer Surgery?
2 months ago
by
Gavin M. Wright, MBBS, FRACS, PhD

0:42
Why Local Cancer Care Access is a Life-or-Death Issue
2 months ago
by
Ryan Funk, MD

0:35
The EMR, AI, and the Fight Against Physician Burnout
2 months ago
by
Marcus Neubauer, MD

0:43
Doing More With Less: The New Lung Surgery Challenge
2 months ago
by
Gavin M. Wright, MBBS, FRACS, PhD

1:12
Upcoming Trials Could Bring New Drug Classes into Prostate Cancer
2 months ago
by
Manojkumar Bupathi, MD, MS

0:35
Why Brain Cancer Treatment Feels Like a Rigged Marathon
3 months ago
by
Clark Chen, MD, PhD

0:26
Your Wednesday Wrap-Up - September 2
3 months ago
by
Sabrina Serani

0:25
The Future of Lymphoma Care Is Moving Forward With Science
3 months ago
by
Krish Patel, MD

0:57
Why Cervical Cancer Screening Shouldn't Stop at 65
3 months ago
by
Noelle Gillette Cloven, MD

0:39
Recognizing Emotional Exhaustion in Burned-Out Colleagues
3 months ago
by
Marcus Neubauer, MD

1:10
Personalizing Therapy After Iberdomide Approval in Myeloma
3 months ago
by
Surbhi Sidana, MD

0:44
Why Oncology Needs Integrated AI Solutions
3 months ago
by
Shaalan Beg, MD, MBA, FASCO

1:14
The Hidden Danger of Postsurgery Glioblastoma Regrowth
3 months ago
by
Clark Chen, MD, PhD

0:49
Using AI to Bring Trials to More Patients
3 months ago
by
Shaalan Beg, MD, MBA, FASCO

0:22
Your Wednesday Wrap-Up - August 26
3 months ago
by
Sabrina Serani

0:46
Balancing AI Efficiency With Human Oversight in Oncology
3 months ago
by
Shaalan Beg, MD, MBA, FASCO

0:27
How Agentic AI Can Slash Clinical Trial Screening Time
3 months ago
by
Shaalan Beg, MD, MBA, FASCO

0:50
Simplifying Chronic GVHD Screening for Physicians
3 months ago
by
Laila Alkhouli, MD

0:35
Helping Oncologists Cut Through the Data Overload
3 months ago
by
Shaalan Beg, MD, MBA, FASCO

0:43
Agentic AI: Turning Fragmented Patient Data Into Clinical Trial Matches
3 months ago
by
Shaalan Beg, MD, MBA, FASCO
Advertisement
Advertisement
Trending on Targeted Onc
1
FDA Approves Neladalkib for Previously Treated Advanced ALK-Positive NSCLC
2
Galinpepimut-S Improves Overall Survival in Phase 3 REGAL Trial in AML
3
FDA Approves Giredestrant Plus Everolimus in ESR1-Mutated Breast Cancer
4
FDA Fast Tracks Elticertinib for Previously Treated EGFR Exon 20 NSCLC
5
